Target: 30-50g healthy fats daily despite suppressed appetite
It is a hormone your intestines release after every meal, a chemical signal between your gut and your brain that says Slow down, youve had enough
The three receptors it targets are: GLP-1 receptors : Help control appetite and slow digestion GIP receptors : Support insulin function and glucose regulation Glucagon receptors : Promote energy expenditure and fat burning This triple-action approach sets Retatrutide apart from current FDA-approved medications, such as semaglutide (found in Ozempic and Wegovy), which only target GLP-1 receptors, and tirzepatide (Mounjaro and Zepbound), which targets both GLP-1 and GIP receptors
But we communicate back and forth all the time. Data from the Advisory Board found that 79% of people taking a GLP-1 medication received the prescription from their primary care provider or a specialist, instead of online or through a medical spa
Because retatrutide does not currently hold regulatory approval in the UK, there are no formal prescribing eligibility criteria in the way that exist for licensed medicines
Contact your GP or NHS 111 if headaches are persistent, worsening, significantly impacting daily activities, or not responding to simple management measures
